# Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation

> **NCT02205411** · NA · TERMINATED · sponsor: **ReliantHeart Inc.** · enrollment: 17 (actual)

## Conditions studied

- Heart Failure
- Cardiac Failure
- Congestive Heart Failure
- Heart Failure, Left-sided

## Interventions

- **DEVICE:** HeartAssist 5® VAD System
- **DEVICE:** Control VAD

## Key facts

- **NCT ID:** NCT02205411
- **Lead sponsor:** ReliantHeart Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Inability to timely enroll.
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02205411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02205411, "Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02205411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*